SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Blair HC, Athanasou NA 2004 Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19: 189199.
  • 2
    Blair HC, Zaidi M, Schlesinger PH 2002 Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 364: 329341.
  • 3
    Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL 1997 Osteopetrosis in mice lacking haematopoietic transcription factor PU. Nature 385: 8184.
  • 4
    Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T 1991 Congenital osteoclast defciency in osteopetrotic (op/op) mice is cured by injections of macrophage colony stimulating factor. J Exp Med 173: 269272.
  • 5
    Gelb BD, Shi GP, Chapman HA, Desnick RJ 1996 Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 12361238.
  • 6
    Li YP, Chen W, Liang Y, Li E, Stashenko P 1999 Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23: 447451.
  • 7
    Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A 2000 Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25: 343346.
  • 8
    Michigami T, Kageyama T, Satomura K, Shima M, Yamaoka K, Nakayama M, Ozono K 2002 Novel mutations in the a3 subunit of vacuolar H+-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone 30: 436439.
  • 9
    Carn G, Koller DL, Peacock M, Hui SL, Evans WE, Conneally PM, Johnston CC Jr, Foroud T, Econs MJ 2002 Sibling pair linkage and association studies between peak bone mineral density and the gene locus for the osteoclast-specific subunit (OC116) of the vacuolar proton pump on chromosome 11p12–13. J Clin Endocrinol Metab 87: 38193824.
  • 10
    Schlesinger PH, Blair HC, Teitelbaum SL, Edwards JC 1997 Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption. J Biol Chem 272: 1863618643.
  • 11
    Brandt S, Jentsch TJ 1995 ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett 377: 1520.
  • 12
    Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ 2001 Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104: 205215.
  • 13
    Kornak U, Bosl MR, Kubisch C 1999 Complete genomic structure of the CLCN6 and CLCN7 putative chloride channel genes. Biochim Biophys Acta 1447: 100106.
  • 14
    Cleiren E, Bénichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, deVernejoul M-C, Van Hul W 2001 Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10: 28612867.
  • 15
    Teti A, Taranta A, Migliaccio S, Degiorgi A, Santandrea E, Villanova I, Faraggiana T, Chellaiah M, Hruska KA 1998 Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene. J Bone Miner Res 13: 5058.
  • 16
    Horton MA, Massey HM, Rosenberg N, Nicholls B, Seligsohn U, Flanagan AM 2003 Upregulation of osteoclast α2β1 integrin compensates for lack of αvβ3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. Br J Haematol 122: 950957.
  • 17
    Teti A, Migliaccio S, Taranta A, Bernardini S, De Rossi G, Luciani M, Iacobini M, De Felice L, Boldrini R, Bosman C, Corsi A, Bianco P 1999 Mechanisms of osteoclast dysfunction in human osteopetrosis: Abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures. J Bone Miner Res 14: 21072117.
  • 18
    Yaroslavskiy BB, Li Y, Ferguson DJP, Kalla SE, Oakley JI, Blair HC 2004 Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J Cell Biochem 91: 962972.
  • 19
    Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA 1996 Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271: 1251712524.
  • 20
    Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong S-S 2000 Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78: 627637.
  • 21
    Carano A, Schlesinger PH, Athanasou NA, Teitelbaum SL, Blair HC 1993 Acid and base effects on avian osteoclast activity. Am J Physiol 264: C694C701.
  • 22
    Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, Dupuis-Girod S, Ellis I, Etzioni A, Fasth A, Fisher A, Gerritsen B, Gulino V, Horwitz E, Klamroth V, Lanino E, Mirolo M, Musio A, Matthijs G, Nonomaya S, Notarangelo LD, Ochs HD, Superti Furga A, Valiaho J, van Hove JL, Vihinen M, Vujic D, Vezzoni P, Villa A 2001 The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 10: 17671773.
  • 23
    Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E, Notarangelo LD, Ramenghi U, Teti A, Van Hove J, Vujic D, Young T, Albertini A, Orchard PJ, Vezzoni P, Villa A 2003 Chloride channel ClCN7 mutations are responsible for severe recessive, dominant and intermediate osteopetrosis. J Bone Miner Res 18: 17401747.
  • 24
    Smith AN, Finberg KE, Wagner CA, Lifton RP, Devonald MA, Su Y, Karet FE 2001 Molecular cloning and characterization of Atp6n1b: A novel fourth murine vacuolar H+-ATPase a-subunit gene. J Biol Chem 276: 4238242388.
  • 25
    Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, Lanino E, Dini G, Morreale G, Ralston SH, Villa A, Vezzoni P, Del Principe D, Cassiani F, Palumbo G, Teti A 2003 Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162: 5768.
  • 26
    Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE 2003 The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18: 615623.
  • 27
    Hentunen TA, Jackson SH, Chung H, Reddy SV, Lorenzo J, Choi SJ, Roodman GD 1999 Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen. Endocrinology 140: 29542961.
  • 28
    Dallas SL, Rosser JL, Mundy GR, Bonewald LF 2002 Proteolysis of latent transforming growth factor-beta (TGF-β)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-β from bone matrix. J Biol Chem 277: 2135221360.
  • 29
    Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE 1997 Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice. Genes Dev 11: 28352844.
  • 30
    Teti A, Blair HC, Schlesinger P, Grano M, Zambonin-Zallone A, Kahn A, Teitelbaum SL, Hruska KA 1989 Extracellular protons acidify osteoclasts, reduce cytosolic calcium and promote expression of cell-matrix attachment structures. J Clin Invest 84: 773780.
  • 31
    Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA 1993 Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem 268: 99019907.
  • 32
    Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL 2003 c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation. J Clin Invest 111: 749758.